GSE247159 metformin oligodendrocyte 8 v 3 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE247159_metformin_oligodendrocyte_8_v_3_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE247159_metformin_oligodendrocyte_8_v_3_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE247159_metformin_oligodendrocyte_8_v_3_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE247159_metformin_oligodendrocyte_8_v_3_human_up.

Results found

Linked to

 

Label

Description

 

Gene

colony stimulating factor 2 receptor subunit alpha

Gene

H3.7 histone (putative)

Gene

lung cancer associated transcript 1

Gene

PCBP1 antisense RNA 1

Gene

sialic acid binding Ig like lectin 5

Gene

MIR223 host gene

Gene

Fc gamma receptor Ib, pseudogene

Gene

POM121 membrane glycoprotein (rat) pseudogene

Gene

ULK4 pseudogene 1

Gene

uncharacterized LOC124904411

  • Gene

    colony stimulating factor 2 receptor subunit alpha


  • Gene

    H3.7 histone (putative)


  • Gene

    lung cancer associated transcript 1


  • Gene

    PCBP1 antisense RNA 1


  • Gene

    sialic acid binding Ig like lectin 5



  • Gene

    Fc gamma receptor Ib, pseudogene


  • Gene

    POM121 membrane glycoprotein (rat) pseudogene


  • Gene

    ULK4 pseudogene 1


  • Gene

    uncharacterized LOC124904411

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.